Clene Inc
Research Clene Inc (CLNN) on Bullrun: market cap USD 56.74M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerCLNN
- ExchangeNASDAQ
- CountryUnited States
- SectorConsumer Defensive
- IndustryPackaged Foods
- CurrencyUSD
- Market capUSD 56.74M
- Financial periodQ1 2026
- RevenueUSD 134.00K
- Net income-USD 33.51M
- Free cash flow-USD 4.53M
- Gross margin82.8%
Valuation Snapshot
latest market cap is USD 56.74M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 200.00K | -USD 26.17M | -USD 18.59M | 78.5% | -4.37 | USD 5.19M | USD 17.79M | -USD 17.59M |
| FY2024 | USD 342.00K | -USD 39.40M | -USD 21.34M | 79.5% | n/a | USD 12.16M | USD 20.84M | -USD 8.86M |
| FY2023 | USD 654.00K | -USD 49.50M | -USD 30.50M | 81.5% | -9.69 | USD 28.82M | USD 32.16M | USD 13.39M |
| FY2022 | USD 473.00K | -USD 29.92M | -USD 44.19M | 94.5% | n/a | USD 18.33M | USD 26.74M | USD 3.24M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 56.74M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 60.66M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 42.96M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 38.52M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 73.82M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 255.48M | n/a | n/a | n/a |
About Clene Inc
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. The company's lead drug candidate is CNM-Au8, which is being studied in various clinical trials, including a completed Phase 2 platform trial to evaluate the safety and efficacy of CNM-Au8 in patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS;
Related stock research
Other Consumer Defensive stocks
Frequently asked questions
What is Clene Inc's market cap?
Clene Inc's market capitalization is USD 56.74M.
What does Clene Inc do?
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics.